國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Druggable lipid signaling pathways

Kihara, Yasuyuki.

Druggable lipid signaling pathways

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Druggable lipid signaling pathwaysedited by Yasuyuki Kihara.
其他作者:	Kihara, Yasuyuki.
出版者:	Cham :Springer International Publishing :2020.
面頁冊數:	vi, 260 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	Lipids.
電子資源:	https://doi.org/10.1007/978-3-030-50621-6
ISBN:	9783030506216$q(electronic bk.)

Druggable lipid signaling pathways
Druggable lipid signaling pathways[electronic resource] /edited by Yasuyuki Kihara. - Cham :Springer International Publishing :2020. - vi, 260 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.12740065-2598 ;. - Advances in experimental medicine and biology ;946..

Preface -- Introduction of Druggable Lipid Signaling Pathway -- Biosynthetic Enzymes of Membrane Glycerophospholipid Diversity as Therapeutic Targets for Drug Development -- Druggable Prostanoid Pathway -- Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress -- Epoxy Fatty Acids are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation -- Druggable Sphingolipid Pathway -- Druggable Lysophospholipid Pathway -- Druggable targets in endocannabinoid signaling -- Drugging the phosphoinositide 3-kinase (PI3K) and phosphatidylinositol 4-kinase (PI4K) family of enzymes for treatment of cancer, immune disorders, and viral/parasitic infections -- Druggable Lipid GPCRs: Past, Present, and Prospects.

This edited work presents a series of reviews focusing on Druggable Lipid Signaling Pathways. It enables researchers in both academic institutions and industry as well as physicians to understand historical aspects of lipid signaling and future directions of drug discovery targeting lipid signaling pathways. This book provides 9 pathways including acyltransferases, prostanoids, leukotrienes, epoxy fatty acids, sphingolipids, lysophospholipids, endocannabinoids, phosphoinositides, and lipid GPCRs. Readers will discover the importance of each lipid signaling pathway that contributes to broad range of diseases including neurological and neuropsychiatric diseases, pain, metabolic syndromes, cardiovascular diseases, cancer, dermatological diseases, fibrosis, inflammation, etc. Also, readers will recognize that many drugs targeting lipid signaling have been clinically used. Drugs currently under development are also discussed in each chapter, which includes some information about clinical trials and strategic drug designs.

ISBN: 9783030506216$q(electronic bk.)

Standard No.: 10.1007/978-3-030-50621-6doiSubjects--Topical Terms:

197421
Lipids.

LC Class. No.: QP751 / .D784 2020

Dewey Class. No.: 612.01577

Druggable lipid signaling pathways
LDR:02980nmm a2200349 a 4500 001 585762
003 DE-He213
005 20201231092236.0
006 m d
007 cr nn 008maaau
008 210323s2020 sz s 0 eng d
020 $a 9783030506216$q(electronic bk.)
020 $a 9783030506209$q(paper)
024 7 $a 10.1007/978-3-030-50621-6 $2 doi
035 $a 978-3-030-50621-6
040 $a GP $c GP
041 0 $a eng
050 4 $a QP751 $b .D784 2020
072 7 $a MBGR $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MBGR $2 thema
072 7 $a PSD $2 thema
082 0 4 $a 612.01577 $2 23
090 $a QP751 $b .D794 2020
245 0 0 $a Druggable lipid signaling pathways $h [electronic resource] / $c edited by Yasuyuki Kihara.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2020.
300 $a vi, 260 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1274
505 0 $a Preface -- Introduction of Druggable Lipid Signaling Pathway -- Biosynthetic Enzymes of Membrane Glycerophospholipid Diversity as Therapeutic Targets for Drug Development -- Druggable Prostanoid Pathway -- Targeting Leukotrienes as a Therapeutic Strategy to Prevent Comorbidities Associated with Metabolic Stress -- Epoxy Fatty Acids are Promising Targets for Treatment of Pain, Cardiovascular Disease and Other Indications Characterized by Mitochondrial Dysfunction, Endoplasmic Stress and Inflammation -- Druggable Sphingolipid Pathway -- Druggable Lysophospholipid Pathway -- Druggable targets in endocannabinoid signaling -- Drugging the phosphoinositide 3-kinase (PI3K) and phosphatidylinositol 4-kinase (PI4K) family of enzymes for treatment of cancer, immune disorders, and viral/parasitic infections -- Druggable Lipid GPCRs: Past, Present, and Prospects.
520 $a This edited work presents a series of reviews focusing on Druggable Lipid Signaling Pathways. It enables researchers in both academic institutions and industry as well as physicians to understand historical aspects of lipid signaling and future directions of drug discovery targeting lipid signaling pathways. This book provides 9 pathways including acyltransferases, prostanoids, leukotrienes, epoxy fatty acids, sphingolipids, lysophospholipids, endocannabinoids, phosphoinositides, and lipid GPCRs. Readers will discover the importance of each lipid signaling pathway that contributes to broad range of diseases including neurological and neuropsychiatric diseases, pain, metabolic syndromes, cardiovascular diseases, cancer, dermatological diseases, fibrosis, inflammation, etc. Also, readers will recognize that many drugs targeting lipid signaling have been clinically used. Drugs currently under development are also discussed in each chapter, which includes some information about clinical trials and strategic drug designs.
650 0 $a Lipids. $3 197421
650 0 $a Cellular signal transduction. $3 188626
650 0 $a Pharmacology. $3 218135
650 0 $a Molecular biology. $3 188737
650 0 $a Diagnosis, Laboratory. $3 265458
650 0 $a Human genetics. $3 192904
650 0 $a Cancer $x Research. $3 341951
650 1 4 $a Molecular Medicine. $3 273932
650 2 4 $a Pharmacology/Toxicology. $3 273652
650 2 4 $a Laboratory Medicine. $3 276727
650 2 4 $a Human Genetics. $3 273658
650 2 4 $a Cancer Research. $3 273660
650 2 4 $a Lipidology. $3 286297
700 1 $a Kihara, Yasuyuki. $3 876982
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
830 0 $a Advances in experimental medicine and biology ; $v 946. $3 557559
856 4 0 $u https://doi.org/10.1007/978-3-030-50621-6
950 $a Biomedical and Life Sciences (SpringerNature-11642)